This group of medications has well-known adverse effects affecting the GI tract, kidneys, cardiovascular system, liver, and blood
Changing paradigms in the management of gout
ii) Moderate risk: Two criteria rated as unclear, or one criterion not met
Among these segments, the type 2 diabetes segment is dominating the market during the forecast period due to when blood glucose levels are high, the GLP-1 receptor agonist plays a key function in boosting insulin release and inhibiting glucagon production
For people with moderate to severe active IBD, corticosteroids include: Prednisone (brand name: Deltasone) Methylprednisolone (brand name: Medrol) Hydrocortisone (brand name: Cortef, Cortril, Hydrocortone) Budesonide (brand names: Entocort EC, Uceris) Budesonide is part of a new class of corticosteroids called nonsystemic steroids because they target the intestine rather than the whole body